We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.2M
AUM Growth
-$16M
Cap. Flow
-$12.8M
Cap. Flow %
-13.02%
Top 10 Hldgs %
57.17%
Holding
92
New
14
Increased
16
Reduced
24
Closed
27

Top Buys

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$1.78M
2
BKNG icon
Booking.com
BKNG
+$1.68M
3
RTK
Rentech, Inc.
RTK
+$1.66M
4
CSII
Cardiovascular Systems, Inc.
CSII
+$1.33M
5
CDZI icon
Cadiz
CDZI
+$1.16M

Top Sells

Rank Stock Value
1
SYT
Syngenta Ag
SYT
+$6.05M
2
LSAK icon
Lesaka Technologies
LSAK
+$3.8M
3
TLPH icon
Talphera
TLPH
+$2.99M
4
CUTR
Cutera, Inc.
CUTR
+$1.56M
5
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
+$1.42M

Sector Composition

Rank Sector Weight
1 Healthcare 44.84%
2 Technology 18.47%
3 Financials 8.1%
4 Communication Services 7.26%
5 Materials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAT
1
DELISTED
BioTelemetry, Inc.
BEAT
$8.29M 8.44%
1,155,974
+57,800
+5% +$460K
MSTR icon
2
Strategy Inc
MSTR
$54.6B
$7.17M 7.3%
510,000
-56,630
-10% -$723K
BFYT
3
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$6.88M 7.01%
558,870
+109,025
+24% +$1.12M
ZLTQ
4
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$6.51M 6.63%
428,704
+40,700
+10% +$696K
FLNA
5
Filana Therapeutics
FLNA
$44.6M
$5.47M 5.57%
135,909
+1,664
+1% +$61.6K
ARCT icon
6
Arcturus Therapeutics
ARCT
$460M
$5.25M 5.35%
43,368
+4,331
+11% +$523K
BDSI
7
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.77M 4.86%
395,276
-122,386
-24% -$1.16M
MEET
8
DELISTED
The Meet Group, Inc. Common Stock
MEET
$4.52M 4.61%
1,662,827
-267,308
-14% -$666K
PCYO icon
9
Pure Cycle
PCYO
$275M
$4.37M 4.45%
646,000
+30,000
+5% +$171K
CSII
10
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.9M 2.95%
92,941
+46,300
+99% +$1.33M
PKT
11
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$2.85M 2.9%
282,090
-1,600
-0.6% -$15.2K
RTK
12
DELISTED
Rentech, Inc.
RTK
$2.63M 2.68%
101,598
+74,642
+277% +$1.66M
SANW
13
DELISTED
S&W Seed Co
SANW
$2.52M 2.56%
20,413
+3,789
+23% +$502K
UI icon
14
Ubiquiti
UI
$35.9B
$2.34M 2.39%
51,863
-11,500
-18% -$452K
DRRX
15
DELISTED
DURECT Corp
DRRX
$2.31M 2.35%
+126,902
New +$1.78M
CDZI icon
16
Cadiz
CDZI
$334M
$1.71M 1.74%
205,479
+152,720
+289% +$1.16M
BKNG icon
17
Booking.com
BKNG
$152B
$1.68M 1.71%
+35,000
New +$1.68M
AXGN icon
18
Axogen
AXGN
$2.78B
$1.53M 1.56%
550,607
– –
CPRX
19
DELISTED
Catalyst Pharmaceutical
CPRX
$1.52M 1.55%
600,000
+317,500
+112% +$678K
P
20
DELISTED
Pandora Media Inc
P
$1.47M 1.5%
49,900
-4,500
-8% -$117K
SHOR
21
DELISTED
ShoreTel, Inc.
SHOR
$1.46M 1.48%
223,560
-20,268
-8% -$146K
ARAY icon
22
Accuray
ARAY
$31.3M
$1.25M 1.27%
141,500
-116,800
-45% -$1.01M
KFX
23
DELISTED
KOFAX LIMITED COM STK
KFX
$1.16M 1.18%
134,900
+81,300
+152% +$656K
ENT
24
DELISTED
Global Eagle Entertainment Inc.
ENT
$1.14M 1.16%
3,672
– –
SRL icon
25
Scully Royalty
SRL
$88.9M
$1.07M 1.09%
28,020
– –
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Sophrosyne Capital held 92 positions worth $98.2M, down 14% from $114M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sophrosyne Capital withdrew a net $12.8M in Q2 2014, closing 27 positions and reducing 24 holdings. Its most notable exit was Syngenta Ag, an estimated $6.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Technology and Financials.

Against the trend, Sophrosyne Capital opened a new position in DURECT Corp worth $2.31M.

  • Sophrosyne Capital's largest Q2 2014 buy was DURECT Corp: 126,902 shares worth $2.31M.
  • Sophrosyne Capital added most to Rentech, Inc. in Q2 2014, an estimated $1.66M increase.
  • Sophrosyne Capital's biggest Q2 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $1.16M.
  • Sophrosyne Capital fully exited Syngenta Ag in Q2 2014, selling an estimated $6.05M.
  • Sophrosyne Capital's ten largest holdings make up 57% of its $98.2M portfolio in Q2 2014.
  • Sophrosyne Capital opened 14 new positions and closed 27 in Q2 2014.
  • Sophrosyne Capital's portfolio value fell 14% quarter-over-quarter to $98.2M.

Based on Sophrosyne Capital's 13F filing for Q2 2014, filed 14 Aug 2014.